Global Pharma Labs, Inc. is a pharmaceutical company. The San Leandro, California-based company is focused on developing solutions for disease processes in patients. Our technology, OA-SYSâ˘, is the first disease-modifying therapy for osteoarthritis, a disease which affects around 55 million people in the USA and approximately 750 million people globally. Global Pharma Labs Inc.âs first drug product, OA-SYSâ˘, will impact those that suffer with osteoarthritis. The immediate impact will be most apparent in developing countries where surgical joint replacement and joint injection therapy is not a practical treatment option for the vast majority of those suffering with the disease. OA-SYS⢠is the first disease modifying medication treatment for osteoarthritis. There are no competitors. Present medication treatment of osteoarthritis is limited to pain medicines which afford only temporary relief of pain, joint injections of steroids which affords only temporary relief of pain within the injected joint, and joint injections of Hyaluronic acid which also affords only temporary relief of pain within the injected joint. Global Pharma Labs Inc. has exclusive patent rights to the first disease modifying medication treatment for osteoarthritis. This patented treatment affords long term relief of joint pain, long term relief of joint stiffness, long term diminution of physical limitations, long term improvement in the ability to perform activities of daily living, reduction or elimination in the need for pain medications, and reduction or elimination in the need for invasive treatment such as joint replacement and joint injections. This treatment is disease modifying, noninvasive, nonnarcotic, and relatively inexpensive.
No articles found.
Global leader in therapeutic ultrasound and present in the market for more than 35...
Global leader in therapeutic ultrasound and pre...
BIONIK is a global pioneering healthcare company on a mission to supply quality-of...
BIONIK is a global pioneering healthcare compan...
H&G Science aims to facilitate the safe and effective treatment of diseases, takin...
H&G Science aims to facilitate the safe and eff...
We are a vertically integrated, clinical stage gene therapy company with four ongo...
We are a vertically integrated, clinical stage ...
FibroGen, Inc. is a leading science-based biopharmaceutical company discovering an...
FibroGen, Inc. is a leading science-based bioph...
Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical compan...
Hepion Pharmaceuticals (Nasdaq: HEPA) is a clin...
Kitov Pharma is an innovative biopharmaceutical drug development company. Leveragi...
Kitov Pharma is an innovative biopharmaceutical...
Flexion Therapeutics is a biopharmaceutical company focused on the development and...
Flexion Therapeutics is a biopharmaceutical com...
Vir integrates diverse innovations in science, technology, and medicine to transfo...
Vir integrates diverse innovations in science, ...
Join the National Investor Network and get the latest information with your interests in mind.